Latest Deals

Credit: Shutterstock/Olga S L

Allez Health raises $60m for diabetes sensor technology

Biosensor company Allez Health raised $60m in Series A+ financing to advance its continuous glucose monitoring (CGM) technology. 

The funding was led by Korean in-vitro diagnostics company Osang Healthcare and will be used to spur growth towards pivotal trials, support regulatory approval filing, and scale manufacturing operations. 

Trinity partners with PulseAI to develop CGM sensor technology

Trinity Biotech partnered with Irish medical artificial intelligence (AI) company PulseAI to enhance its continuous glucose monitor (CGM) biosensor technology. Trinity added the CGM technology to its portfolio as part of the acquisition of WaveForm Technologies, in January. The company paid $12.5m in cash to WaveForm along with 9 million of its shares to Preceptive, WaveForm’s parent company. 

British device manufacturer Entaco secures £1m investment following buyout

UK-based medical device manufacturer Entaco has been acquired in a management buyout, securing a £1m ($1.26m) investment from private equity company Traditum.   The buyout was led by Entaco’s managing director Steve Brown, who will now serve as group CEO. The investment will be used to enhance operational efficiencies and expand personnel, according to the company’s announcement on 17 May. 

Source: Pharmaceutical Technology

Meacor secures $15m for heart valve repair technology development

Medical device company Meacor closed a $15m Series A funding round, a significant step forward in the development of its transcatheter heart valve repair technology. This investment will fuel the advancement of Meacor’s Cryocinch system, which aims to offer a new minimally invasive treatment for mitral and tricuspid valve regurgitation.